期刊文献+

成人急性淋巴细胞白血病骨髓中miR-34a的表达及其在细胞耐药中的意义 被引量:3

Expression of miR-34a in Bone Marrow of Adult Acute Lymphoblastic Leukemia and Its Significance in Cell Drug Resistance
下载PDF
导出
摘要 目的:探讨miR-34a在成人急性淋巴细胞白血病(ALL)骨髓中的表达及其与耐药性的关系。方法:47例初诊ALL患者,分别于初诊和复发或完全缓解时留取骨髓样品,初诊-完全缓解组标本26对,初诊-复发组标本21对。利用实时荧光定量PCR对患者骨髓样品、人CCRF-CEM细胞株及其耐药株CEM-C1细胞中miR-34a表达水平进行检测。利用电穿孔转染法抑制CCRF-CEM细胞并上调CEM-C1细胞中miR-34a表达,分别用不同浓度喜树碱进行培养,利用CCK-8法对细胞存活情况进行分析,计算细胞增殖抑制率(%)和耐药指数(RI)。结果:初诊-完全缓解组中,初诊时患者骨髓样品中miR-34a表达水平显著低于完全缓解时和对照组,差异具有统计学意义(P<0.05),初诊-复发组中,初诊时和复发时患者骨髓样品中miR-34a相对表达量均低于对照组,差异均有统计学意义(P<0.05);miR-34a在CEM-C1细胞中表达水平为(2.64±1.37),显著低于CCRF-CEM细胞中的(5.14±2.06)(P<0.05);转染miR-34a抑制物的CCRF-CEM细胞中miR-34a表达水平为(3.14±1.15),显著低于miRNA抑制剂阴性对照CCRF-CEM细胞(P<0.05),转染miR-34a抑制物的CCRF-CEM细胞增殖抑制率显著高于转染阴性对照细胞(P<0.05),IC_(50)分别为28.73和2167.00 ng/ml,RI=75.43;转染miR-34a模拟物的CEM-C1细胞中miR-34a表达水平(5.06±1.73),显著高于miRNA模拟物阴性对照CEM-C1细胞(P<0.05),转染miR-34a模拟物的CCRF-C1细胞增殖抑制率显著低于转染阴性对照细胞(P<0.05),IC_(50)分别为112.57 ng/m L和1.27 ng/m L,RI=88.64。结论:miR-34a在成人ALL骨髓样品中呈低表达,可能与ALL复发及耐药性的发生有关。 Objective:To investigate the expressions of miR-34 a in bone marrow of adult acute lymphoblastic leukemia(ALL) and its relationship with drug resistance.Methods:Forty- seven cases of newly diagnosed adult ALL were selected and their bone marrow samples were taken at the time of newly diagnosed and relapsed or complete remission;26 pairs of specimens were in newly diagnosed-complete remission group,and 21 pairs of specimens were in newly diagnosed-relapse group.The expressions of miR-34 a in bone marrow samples,CCRF-CEM cells and resistant CEM-C1 cell strains were detected by real-time quantitative PCR.The expression of miR-34 a in CCRF-CEM cells was inhibited and was increased in CEM-C1 cells detected by electroporation transfection method.All the cells were incubated at different concentration of camptothecin.The cell survival was analyzed by CCK-8 method,the cell proliferation inhibition rate(%) and resistance index(RI) were calculated.Results:In newly diagnosed- complete remission group,the miR-34 a expression at newly diagnosis was significantly lower than that in complete remission and the control group,the differences were statistically significant(P < 0.05).In newly diagnosed- relapsed group,the miR-34 a expressions at newly diagnosis and relapse were lower than those in the control group,the differences were statistically significant(P <0.05).The expression level in CEM-C1 cells was(2.64 ± 1.37) which significantly lower than that in CCRF-CEM cells(5.14 ±2.06),the differences were statistically significant(P < 0.05).The expression level of miR-34 a in CCRF-CEM cells transfected with miR-34 a inhibitor was(3.14 ± 1.15),which significantly lower than that in the miRNA inhibitor- negative control group,the difference was statistically significant(P < 0.05).The cell proliferation inhibition rate of CCRF-CEM cells transfected with miR-34 a inhibitor was significantly higher than that in the negative control transfectedcells(P < 0.05),the IC50 was 28.73 ng /mL and 2167.00 ng /mL respectively,and RI= 75.43.The expression level of miR-34 a in CEM-C1 cells transfected with miR-34 a mimic was(5.06 ± 1.73),which was significantly higher than that in the miRNA mimics transteted- negative control CEM-C1 cells(P < 0.05).The proliferation inhibition rate in CEM-C1 cells transfected with miR-34 a mimic was significantly lower than that in the negative control- transfected cells(P <0.05).The IC50 was 112.57 ng/mL and 1.27 ng/mL respectively,and the RI= 88.64.Conclusion:The expression of miR-34 a in bone marrow samples of adult ALL is low which may be associated with the relapse and drug resistance of ALL.
出处 《中国实验血液学杂志》 CAS CSCD 北大核心 2016年第2期336-340,共5页 Journal of Experimental Hematology
关键词 急性淋巴细胞白血病 成人 MIR-34A 表达 耐药性 acute lymphoblastic leukemia adult miR-34a expression drug resistance
  • 相关文献

参考文献6

二级参考文献72

  • 1顾龙君.儿童急性淋巴细胞白血病诊疗建议(第三次修订草案)[J].中华儿科杂志,2006,44(5):392-395. 被引量:472
  • 2Huang HiLin H,Zhang X,et al.Resveratrol reverses temozolomide re-sistance by downregulation of MGMT in T98G glioblastoma cells bythe NF-KB-dependent pathway.Oncol Rep,2012,27:2050-2056.
  • 3Napetschnig J,Wu H.Molecular basis of NF-kB signaling.Annu RevBiophys,2013,42:443-468.
  • 4Wang L,Meng Q,Wang C,et al.Dioscin restores the activity of theanticancer agent adriamycin in multidrug-resistant human leukemiaK562/adriamycin cells by down-regulating MDRl via a mechanism in-volving NF-kB signaling inhibition.J Nat Prod,2013,76:909-914.
  • 5Caporali S,Levati L.NF-kB is activated in response to temozolomidein an AKT dependent manner and confers protection against thegrowth suppressive effect of the drug.J Transl Med,2012,10:252.
  • 6Moricke A,Zimmermann M,Reiter A,et al.Long term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000[J].Leukemia,2010,24(2):265-284.
  • 7Pui CH,Mullighan CG,Evans WE,et al.Pediatric acute lymphoblastic leukemia:where are we going and how do we get there?[J].Blood,2012,120(6):1165-1174.
  • 8Gaynon PS.Childhood acute lymphoblastic leukaemia and relapse[J].Br J Haematol,2005,131(5):579-587.
  • 9Nguyen K,Devidas M,Cheng SC,et al.Factors influencing survival after relapse from acute lymphoblastic leukemia:a Children’s Oncology Group study[J].Leukemia,2008,22(12):2142-2150.
  • 10Tallen G,Ratei R,Mann G,et al.Long-term outcome in children with relapsed acute lymphoblastic leukemia after time-point and site-of-relapse stratification and intensified short-course multidrug chemotherapy:results of trial ALL-REZ BFM 90[J].J Clin Oncol,2010,28(14):2339-2347.

共引文献25

同被引文献19

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部